- Home
- KPTI vs GRWG Comparison
KPTI vs GRWG Comparison
Compare KPTI & GRWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPTI
- GRWG
- Stock Information
- Founded
- KPTI 2008
- GRWG 2008
- Country
- KPTI United States
- GRWG United States
- Employees
- KPTI N/A
- GRWG N/A
- Industry
- KPTI Biotechnology: Pharmaceutical Preparations
- GRWG RETAIL: Building Materials
- Sector
- KPTI Health Care
- GRWG Consumer Discretionary
- Exchange
- KPTI Nasdaq
- GRWG Nasdaq
- Market Cap
- KPTI 90.7M
- GRWG 82.9M
- IPO Year
- KPTI 2013
- GRWG N/A
- Fundamental
- Price
- KPTI $0.62
- GRWG $1.37
- Analyst Decision
- KPTI Strong Buy
- GRWG Hold
- Analyst Count
- KPTI 4
- GRWG 5
- Target Price
- KPTI $5.00
- GRWG $2.75
- AVG Volume (30 Days)
- KPTI 676.1K
- GRWG 518.8K
- Earning Date
- KPTI 02-27-2025
- GRWG 03-12-2025
- Dividend Yield
- KPTI N/A
- GRWG N/A
- EPS Growth
- KPTI N/A
- GRWG N/A
- EPS
- KPTI N/A
- GRWG N/A
- Revenue
- KPTI $148,442,000.00
- GRWG $200,882,000.00
- Revenue This Year
- KPTI $5.47
- GRWG N/A
- Revenue Next Year
- KPTI $6.33
- GRWG N/A
- P/E Ratio
- KPTI N/A
- GRWG N/A
- Revenue Growth
- KPTI 1.77
- GRWG N/A
- 52 Week Low
- KPTI $0.58
- GRWG $1.35
- 52 Week High
- KPTI $1.95
- GRWG $3.38
- Technical
- Relative Strength Index (RSI)
- KPTI 40.06
- GRWG 30.12
- Support Level
- KPTI $0.65
- GRWG $1.37
- Resistance Level
- KPTI $0.70
- GRWG $1.46
- Average True Range (ATR)
- KPTI 0.05
- GRWG 0.07
- MACD
- KPTI -0.00
- GRWG -0.01
- Stochastic Oscillator
- KPTI 11.00
- GRWG 3.70
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, advanced indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.